KNOW THE FOLLOWING CONCEPTS:1. Pharmacokinetics

2. Difference in oral Formularies

3. Side Effects versus Adverse Effects

4. Extrapyramidal effects: (What is the treatment) a. Acute Dystonia b. Parkinsonism c. Akathisia d. Tardive Dyskinesia

5. Status Epilepticus/Why would you use a benzodiazepine?

6. binding to a receptor a. Agonist b. Partial-Agonist c. Antagonist

7. Tolerance

8. Dependence

9. Addiction

10. Half-life: Interpret

11. Serotonin syndrome

12. Drug Holiday

13. Neuroleptic Malignant Syndrome

14. Anticholinergic

15. Cholinergic

16. Teratogenic

17. Know All the serum levels we discussed

18. Know Antidote/Treatment for Benzo & Phenobarbital overdoses

Module 2:1. Parkinson’s Disease: Pathophysiology, characterization, Goal of therapy, Patient education a. levodopa/carbidopa (together)1

b. Pramipexole c. Entacapone d. Benztropine

2. Alzheimer’s Disease: Pathophysiology, characterization, Goal of therapy, Patient education a. Cholinesterase Inhibitor: Donepezil/ rivastigmine

3. Multiple Sclerosis: Pathophysiology, characterization, Goal of therapy, Patient education a. Immunomodulator: Interferon Beta 1-ab. Fingolimod c. Natalizumab d. Glatiramer acetate e. Interferon beta-1b

4. Attention-deficit/hyperactivity disorder: Pathophysiology, characterization, Goal of therapy,Patient education

5. Muscle Spasm & spacticityCentral i. Baclofen ii. carisoprodol iii. Cyclobenzaprine iv. TizanidineDirect v. Dantrolene

6. Seizure/EpilepsyTraditional Antiseizure Drugs i. Phenytoin ii. Carbamazepine iii. Valproate iv. Ethosuximide v. Phenobarbital New Generation Antiseizure Drugs i. Oxcarbazepine ii. Lamotrigine7. ADHD a. Central Nervous System Stimulant i. Dextroamphetamine ii. Lisdexamfetamine iii. Methylphenidate

Module 3:8. Schizophrenia: Pathophysiology, characterization, Goal of therapy, Patient education a. Conventional/Traditional Antipsychotic/Traditional Neuroleptic: first-generation antipsychotic (FGA)i. Chlorpromazine ii. Haloperidol b. Atypical antipsychotic Drugs (SGA)i. Risperidone ii. Olanzapine [Zyprexa]iii. clozapine

9. Depression: Pathophysiology, characterization, Goal of therapy, Patient education a. Tricyclic antidepressants (TCAs)i. Amitriptyline ii. Imipramine b. Selective serotonin reuptake inhibitors (SSRIs)i. Fluoxetine: ii. Sertraline c. Serotonin/norepinephrine reuptake inhibitors i. Duloxetine ii. Venlafaxine d. Monoamine oxidase inhibitors (MAOIs)e. Atypical antidepressants

10. Bipolar Disorder: Pathophysiology, characterization, Goal of therapy, Patient education (DrugRegimen)a. Lithium b. Valproic Acid (Divalproex sodium)c. Carbamazapine d.

11. Insomnia/Sedative: Pathophysiology, characterization, Goal of therapy, Patient education a. Benzodiazepine (pam/lam)b. Flumazenil c. Barbiturates i. Phenobarbital

12. Anxiety Disorder: Pathophysiology, characterization, Goal of therapy, Patient Education

a. Buspirone

Complete Answer: